TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

D’Costa, Zenobia C.; Higgins, Catherine; Ong, Chee Wee; Irwin, Gareth W.; Boyle, David; McArt, Darragh G.; McCloskey, Karen; Buckley, Niamh E.; Crawford, Nyree T.; Thiagarajan, Lalitha; Murray, James; Kennedy, Richard D.; Mulligan, Karl A.; Harkin, D. Paul; Waugh, David J.J.; Scott, Chris J.; Salto-Tellez, Manuel; Williams, Richard; Mullan, Paul B.

doi:10.18632/oncotarget.1707

Journal article 554 views

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Zenobia C. D’Costa, Catherine Higgins, Chee Wee Ong, Gareth W. Irwin, David Boyle, Darragh G. McArt, Karen McCloskey, Niamh E. Buckley, Nyree T. Crawford, Lalitha Thiagarajan, James Murray

, Richard D. Kennedy, Karl A. Mulligan, D. Paul Harkin, David J.J. Waugh, Chris J. Scott, Manuel Salto-Tellez, Richard Williams, Paul B. Mullan

Oncotarget, Volume: 5, Issue: 6, Pages: 1609 - 1620

Swansea University Author: James Murray

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.18632/oncotarget.1707

Published in:	Oncotarget
ISSN:	1949-2553
Published:	Impact Journals, LLC 2014
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa56402

Keywords:	TBX2, CST6, LGMN, breast cancer
College:	Faculty of Medicine, Health and Life Sciences
Issue:	6
Start Page:	1609
End Page:	1620

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Similar Items